Evidence map›Paper›PMID 40389599›Full record

ArticleNPJ digital medicine2025

Deep Gaussian process with uncertainty estimation for microsatellite instability and immunotherapy response prediction from histology.

Sunho Park, Morgan F Pettigrew, Yoon Jin Cha, In-Ho Kim, Minji Kim, Imon Banerjee, Isabel Barnfather, Jean R Clemenceau, Inyeop Jang, Hyunki Kim and 11 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sunho Park *Vanderbilt University Medical Center, Nashville, TN, USA.
Morgan F Pettigrew *Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yoon Jin Cha *Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
In-Ho Kim *Department of Internal Medicine, Division of Medical Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Minji KimVanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0009-0009-6787-0354
Imon BanerjeeDepartment of Radiology, Mayo Clinic, Phoenix, AZ, USA.
Isabel BarnfatherDepartment of Artificial Intelligence and Informatics, Mayo Clinic, Jacksonville, FL, USA.
Jean R ClemenceauVanderbilt University Medical Center, Nashville, TN, USA.
Inyeop JangVanderbilt University Medical Center, Nashville, TN, USA.
Hyunki KimDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Younghoon KimDepartment of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Rish K PaiDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
Jeong Hwan ParkDepartment of Pathology, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
N Jewel SamadderDepartment of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.
Kyo Young SongDivision of Gastrointestinal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ji-Youn SungDepartment of Pathology, College of Medicine, Kyung Hee University hospital, Kyung Hee University, Seoul, Korea.
Jae-Ho CheongDepartment of Surgery, Department of Biochemistry and Molecular Biology, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea. jhcheong@yuhs.ac.
Jeonghyun KangDepartment of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. ravic@naver.com.
Sung Hak LeeDepartment of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. hakjjang@gmail.com.
Sam C WangDivision of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. Sam.Wang@UTSouthwestern.edu.
Tae Hyun HwangVanderbilt University Medical Center, Nashville, TN, USA. taehyun.hwang@vumc.org.

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
University of California Minority Patient-Derived Xenograft (PDX) Development and Trial Center (UCaMP) to Reduce Cancer Health DisparitiesU54CA233306 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARVAJAL CARMONA, LUIS GUILLERMO, CHEN, MOON SHAO-CHUANG · 2018 to 2022
$6.8M
University of California and UT Southwestern D-PDTCU54CA283766 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Luis Guillermo Carvajal Carmona, Jonathan W Riess · 2023 to 2026
$5.9M
Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D)U01CA294518 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Paul F Mansfield, Linghua Wang · 2024 to 2026
$5.4M
Determining the role of germline CDH1 variants in gastric cancer outcome disparities in Hispanic/Latino patientsR37CA265967 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sam C. Wang · 2022 to 2026
$3.6M
Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancerR01CA276690 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Tae Hyun Hwang, Sam C. Wang · 2024 to 2026
$2.0M
Sox9 signaling in lung adenocarcinomaR01CA190578 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI PINE, SHARON R. · 2014 to 2018
$1.7M
National Research Foundation of Korea (NRF) NRF-2022R1A2C2010644NCI NIH HHS R01 CA190578NCI NIH HHS R01 CA276690NCI NIH HHS R37 CA265967NCI NIH HHS U01 CA167551NCI NIH HHS U01 CA294518NCI NIH HHS U54 CA233306NCI NIH HHS U54 CA283766
6 · The paper itself

Abstract

Determining tumor microsatellite status has significant clinical value because tumors that are microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) respond well to immune checkpoint inhibitors (ICIs) and oftentimes not to chemotherapeutics. We propose MSI-SEER, a deep Gaussian process-based Bayesian model that analyzes H&E whole-slide images in weakly-supervised-learning to predict microsatellite status in gastric and colorectal cancers. We performed extensive validation using multiple large datasets comprised of patients from diverse racial backgrounds. MSI-SEER achieved state-of-the-art performance with MSI prediction by integrating uncertainty prediction. We achieved high accuracy for predicting ICI responsiveness by combining tumor MSI status with stroma-to-tumor ratio. Finally, MSI-SEER's tile-level predictions revealed novel insights into the role of spatial distribution of MSI-H regions in the tumor microenvironment and ICI response.

Identifiers

PMID40389599
PMCPMC12089473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.